Afghanistan vs Central African Republic: Current health expenditure (CHE) per capita in US$
Afghanistan
59.07
in 2023
Central African Republic
53.81
in 2023
Afghanistan rank
168th
Central African Republic rank
171st
Current health expenditure (CHE) per capita in US$ over time
- Afghanistan
- Central African Republic
How they compare
Afghanistan currently reports 59.07 against 53.81 in Central African Republic, a difference of 5.26.
That makes Afghanistan's figure about 1.1 times Central African Republic's.
Across all 22 years both countries report, Afghanistan has been ahead every year.
Afghanistan ranks 168th and Central African Republic ranks 171st of 194 countries.
Afghanistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Central African Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.21 | 15.29 | 12.92 | Afghanistan |
| 2010s | 60.07 | 24.95 | 35.12 | Afghanistan |
| 2020s | 75.33 | 47.65 | 27.68 | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher current health expenditure (che) per capita in us$, Afghanistan or Central African Republic?
- Afghanistan, at 59.07 against 53.81 in Central African Republic as of 2023.
- What is the difference in current health expenditure (che) per capita in us$ between Afghanistan and Central African Republic?
- 5.26, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Central African Republic?
- 22 years are reported by both, from 2002 to 2023.
- How do Afghanistan and Central African Republic rank globally for current health expenditure (che) per capita in us$?
- Afghanistan ranks 168th and Central African Republic ranks 171st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Current health expenditure (CHE) per capita in US$. Statizoid refreshes it automatically from the source and publishes the full history for both places.